Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method

Roujian Lu1, Peihua Niu1, Li Zhao1

  • 1Key Laboratory of Biosafety, National Health and Family Planning Commission, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.

China CDC Weekly
|October 1, 2021
PubMed

Insights

Sanger sequencing provides a cost-effective method for obtaining complete severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from clinical samples. This technique enables the monitoring of viral genetic variations in COVID-19 infections without expensive equipment.

Area of Science:

  • Virology
  • Genomics
  • Molecular Biology

Background:

  • Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
  • Complete SARS-CoV-2 genomes have been previously sequenced using next-generation sequencing (NGS).

Purpose of the Study:

  • To provide technical data for sequencing complete SARS-CoV-2 genomes from clinical samples using the Sanger sequencing method.
  • To demonstrate the feasibility of using Sanger sequencing for viral genome analysis.

Main Methods:

  • Sanger sequencing was employed to obtain complete genomes of SARS-CoV-2 from clinical samples.
  • Two complete SARS-CoV-2 genomes (WH19004-S and GX0002) were successfully sequenced.
  • Single nucleotide polymorphisms (SNPs) were identified in specific regions of the WH19004-S genome.

Main Results:

  • Complete genome sequences of SARS-CoV-2 were obtained using the Sanger method.
  • Two specific single nucleotide polymorphisms (SNPs) were identified in the ORF7a and ORF8 regions of the WH19004-S genome.
  • The obtained sequences were of high quality.

Conclusions:

  • Sanger sequencing is a viable and cost-effective alternative to NGS for complete SARS-CoV-2 genome sequencing.
  • This method can generate high-quality data for monitoring viral genetic variations in COVID-19.
  • It supports public health surveillance of SARS-CoV-2 without the need for expensive equipment.

Related Concept Videos

Sanger Sequencing01:57

Sanger Sequencing

DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
761.7K
RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.6K
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
94.2K